4
Changes in Ownership
10x Genomics, Inc. Filed Acc 0001209191-20-057068
Chief Financial Officer sold 10,000 shares at an average $136.57 ($1,365,723)
- Chief Financial Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
McAnear Justin J. · Chief Financial Officer
Table I: Non-derivative
11 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-11-02 | Exercise or conversion : show line 1 in the form | +7,100 | $5.04 | $35,784 | 8,033 | D |
| 2020-11-02 | Sale : show line 2 in the form | −1,324 | $135.40 | $179,264 | 6,709 | D |
| 2020-11-02 | Sale : show line 3 in the form | −4,376 | $136.10 | $595,581 | 2,333 | D |
| 2020-11-02 | Sale : show line 4 in the form | −500 | $137.10 | $68,552 | 1,833 | D |
| 2020-11-02 | Sale : show line 5 in the form | −500 | $137.99 | $68,995 | 1,333 | D |
| 2020-11-02 | Sale : show line 6 in the form | −400 | $139.21 | $55,684 | 933 | D |
| 2020-11-03 | Exercise or conversion : show line 7 in the form | +2,900 | $5.04 | $14,616 | 3,833 | D |
| 2020-11-03 | Sale : show line 8 in the form | −200 | $135.55 | $27,110 | 3,633 | D |
| Open-market sales · 10,000 sh · avg $136.57 · $1,365,723 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-11-02 | Exercise or conversion : show line 12 in the form Stock Option (right to buy) | −7,100 | $5.04 | 2028-11-02 | 7,100 | 512,900 | D |
| 2020-11-03 | Exercise or conversion : show line 13 in the form Stock Option (right to buy) | −2,900 | $5.04 | 2028-11-02 | 2,900 | 510,000 | D |
Loading xslF345X03/doc4.xml…